18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

NCT02175745 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-03-20

Study results available
· View outcomes & findings →

Summary

To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.

Conditions

  • Adult Anaplastic Ependymoma
  • Adult Anaplastic Oligodendroglioma
  • Adult Brain Stem Glioma
  • Adult Diffuse Astrocytoma
  • Adult Giant Cell Glioblastoma
  • Adult Glioblastoma
  • Adult Gliosarcoma
  • Adult Mixed Glioma
  • Adult Oligodendroglioma
  • Adult Pilocytic Astrocytoma
  • Adult Pineal Gland Astrocytoma
  • Adult Subependymal Giant Cell Astrocytoma
  • Childhood High-grade Cerebellar Astrocytoma
  • Childhood High-grade Cerebral Astrocytoma
  • Childhood Low-grade Cerebellar Astrocytoma
  • Childhood Low-grade Cerebral Astrocytoma
  • Recurrent Adult Brain Tumor
  • Recurrent Childhood Anaplastic Astrocytoma
  • Recurrent Childhood Anaplastic Oligoastrocytoma
  • Recurrent Childhood Anaplastic Oligodendroglioma
  • Recurrent Childhood Brain Stem Glioma
  • Recurrent Childhood Cerebellar Astrocytoma
  • Recurrent Childhood Cerebral Astrocytoma
  • Recurrent Childhood Diffuse Astrocytoma
  • Recurrent Childhood Fibrillary Astrocytoma
  • Recurrent Childhood Gemistocytic Astrocytoma
  • Recurrent Childhood Giant Cell Glioblastoma
  • Recurrent Childhood Glioblastoma
  • Recurrent Childhood Gliomatosis Cerebri
  • Recurrent Childhood Gliosarcoma
  • Recurrent Childhood Oligoastrocytoma
  • Recurrent Childhood Oligodendroglioma
  • Recurrent Childhood Pilomyxoid Astrocytoma
  • Recurrent Childhood Protoplasmic Astrocytoma
  • Recurrent Childhood Subependymal Giant Cell Astrocytoma
  • Recurrent Childhood Visual Pathway and Hypothalamic Glioma
  • Recurrent Childhood Visual Pathway Glioma
  • Untreated Childhood Anaplastic Astrocytoma
  • Untreated Childhood Anaplastic Oligoastrocytoma
  • Untreated Childhood Anaplastic Oligodendroglioma
  • Untreated Childhood Brain Stem Glioma
  • Untreated Childhood Cerebellar Astrocytoma
  • Untreated Childhood Cerebral Astrocytoma
  • Untreated Childhood Diffuse Astrocytoma
  • Untreated Childhood Fibrillary Astrocytoma
  • Untreated Childhood Gemistocytic Astrocytoma
  • Untreated Childhood Giant Cell Glioblastoma
  • Untreated Childhood Glioblastoma
  • Untreated Childhood Gliomatosis Cerebri
  • Untreated Childhood Gliosarcoma
  • Untreated Childhood Oligoastrocytoma
  • Untreated Childhood Oligodendroglioma
  • Untreated Childhood Pilomyxoid Astrocytoma
  • Untreated Childhood Protoplasmic Astrocytoma
  • Untreated Childhood Subependymal Giant Cell Astrocytoma
  • Untreated Childhood Visual Pathway and Hypothalamic Glioma
  • Untreated Childhood Visual Pathway Glioma

Interventions

DRUG

18F-fluoro-dihydroxyphenylalanine

Administered intravenously (IV)

PROCEDURE

Positron emission tomography (PET)

Component of an 18F-FDOPA PET/CT or PET/MRI scan

PROCEDURE

Computed tomography (CT)

Component of an 18F-FDOPA PET/CT

PROCEDURE

Magnetic resonance imaging

Component of an 18F-FDOPA PET/MRI

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Erik Mittra

    lead OTHER

Principal Investigators

  • Erik Mittra, MD, PhD · Stanford University Hospitals and Clinics

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-08-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02175745 on ClinicalTrials.gov